{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:00:56Z","timestamp":1781168456108,"version":"3.54.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007265","name":"Boston University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jaad.2018.12.040","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T02:02:35Z","timestamp":1548900155000},"page":"617-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk factors for acne development in the first 2\u00a0years after initiating masculinizing testosterone therapy among transgender men"],"prefix":"10.1016","volume":"81","author":[{"given":"Jason Andrew","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin Elizabeth","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison Ruth","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2018.12.040_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijwd.2016.11.007","article-title":"Dermatologic care of the transgender patient","volume":"3","author":"Ginsberg","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaad.2018.12.040_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.141.10.1303","article-title":"Dermatology-related epidemiologic and clinical concerns of men who have sex with men, women who have sex with women, and transgender individuals","volume":"141","author":"Katz","year":"2005","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.12.040_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jsm.12366","article-title":"Short- and long-term clinical skin effects of testosterone treatment in trans men","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"3","key":"10.1016\/j.jaad.2018.12.040_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1507\/endocrj.EJ12-0319","article-title":"Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder","volume":"60","author":"Nakamura","year":"2013","journal-title":"Endocr J"},{"issue":"6","key":"10.1016\/j.jaad.2018.12.040_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.21037\/tau.2016.09.04","article-title":"Hormone therapy for transgender patients","volume":"5","author":"Unger","year":"2016","journal-title":"Transl Androl Urol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218331153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218331153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:50:08Z","timestamp":1759272608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218331153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0190962218331153"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.12.040","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for acne development in the first 2\u00a0years after initiating masculinizing testosterone therapy among transgender men","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}